| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Scopolamine measurement |
Component |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine hydrobromide [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine 600micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine 500micrograms/72hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 1mg/72hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 400micrograms/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 600micrograms/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Scopolamine 1.5mg/unt patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Scopolamine 0.5mg/24 hr patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Ophthalmic hyoscine hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Scopolamine hydrobromide (substance) |
Is a |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine butylbromide |
Is a |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine (substance) |
Is a |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine hydrobromide [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing scopolamine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing scopolamine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing scopolamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Accidental poisoning by hyoscine |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Intentional hyoscine poisoning |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by hyoscine |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine methonitrate |
Is a |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Allergy to hyoscine |
Causative agent (attribute) |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
2 |
| Hyoscine butylbromide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Scopolamine hydrobromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine methonitrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing scopolamine in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
3 |
| Product containing atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
3 |
| Hyoscine 13.889 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine 13.889 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine overdose of undetermined intent |
Causative agent (attribute) |
False |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Accidental hyoscine overdose |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Intentional hyoscine overdose |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine overdose |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing papaveretum and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing scopolamine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing scopolamine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
3 |
| Product containing only papaveretum and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only scopolamine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only scopolamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only scopolamine in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Atropine and hyoscine and hyoscyamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
3 |
| Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to hyoscine |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
| Hyoscine adverse reaction |
Causative agent (attribute) |
True |
Scopolamine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]